Actin gamma 1 pseudogene 21 (ACTG1P21)

Actin gamma 1 pseudogene 21 (ACTG1P21) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a protein-coding gene (in this case, ACTG1 for gamma-actin), but it is nonfunctional and does not produce a protein product[5]. Pseudogenes arise through gene duplication or retrotransposition events and often contain mutations or deletions that prevent expression or functionality. There is no evidence that ACTG1P21 acts as a receptor, enzyme, transporter, or any other characterized drug target, nor is there evidence linking it to any specific biological function, disease, or drug interaction. As a result, it is not considered a therapeutic target, and any attempts to map clinical or pharmacological relevance to this pseudogene would be incorrect. Specifically, ACTG1P21 is a pseudogene and not an active gene product[5], it is not a therapeutic target, and there is no evidence it is involved in signaling, disease, drug interaction, or used as a biomarker. If you intended to query ACTG1 (Actin gamma 1), a cytoskeletal protein with disease significance, that is a distinct and active gene/protein unrelated to the pseudogene ACTG1P21[4].

Other names

Actin gamma 1 pseudogene 21